Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$413.6K
8.27K shares
What this filing means
KAKKIS EMIL D plans to sell 8.27K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $413.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/10/2024ACC: 0001971857-24-000811
DirectorOfficer· President & CEO
Since Mar 2026
8.27K
Shares to sell
$413.6K
Approx. market value
8.27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
FOUNDERS SHARES
CASH
4/27/2010
8.27KTotal acquired8.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/27/2010 | FOUNDERS SHARES CASH | 8.27K | — |
| Total | 8.27K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.27K
Market value
$413.6K
12/10/2024
Total
Units
8.27K
Value
$413.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/10/2024 | 8.27K | $413.6K | NASDAQ | Planned |
| Total | 8.27K | $413.6K | ||